Pretreatment integrase strand transfer inhibitor resistance in Tianjin, China
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pretreatment integrase strand transfer inhibitor resistance in Tianjin, China
Authors
Keywords
-
Journal
CHINESE MEDICAL JOURNAL
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-11-03
DOI
10.1097/cm9.0000000000002898
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
- (2023) Adam Trickey et al. Lancet HIV
- Pre‐treatment and acquired antiretroviral drug resistance among people living with HIV in Tianjin, China
- (2022) Liying Gao et al. HIV MEDICINE
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
- (2022) Rajesh T. Gandhi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Primary resistance to integrase inhibitors in Shenzhen
- (2022) Yue Zhu et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Drug Resistance to Integrase Strand-Transfer Inhibitors among HIV-1-Infected Adults in Guangdong, China
- (2022) Yun Lan et al. Pathogens
- HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistance
- (2021) Nokuzola Mbhele et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Optimizing Treatment for Adults with HIV/AIDS in China: Successes over Two Decades and Remaining Challenges
- (2020) Wei Cao et al. Current HIV/AIDS Reports
- Lack of HIV-1 integrase inhibitor resistances among 392 antiretroviral-naïve subjects in a tertiary care hospital in Beijing, China
- (2019) Lifeng Liu et al. AIDS
- Antiviral activity of HIV‐1 integrase strand‐transfer inhibitors against mutants with integrase resistance‐associated mutations and their frequency in treatment‐naïve individuals
- (2019) Nicolas A. Margot et al. JOURNAL OF MEDICAL VIROLOGY
- Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017
- (2019) Tahvi D Frank et al. Lancet HIV
- Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen
- (2018) Charlotte Charpentier et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Accumulation of multiple mutations in vivo confers cross-resistance to new and existing integrase inhibitors
- (2018) Wendy W Zhang et al. JOURNAL OF INFECTIOUS DISEASES
- HIV drug resistance against strand transfer integrase inhibitors
- (2017) Kaitlin Anstett et al. Retrovirology
- Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
- (2017) Adam Trickey et al. Lancet HIV
- Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
- (2016) Alison J. Rodger et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Antiretroviral Therapy for the Prevention of HIV-1 Transmission
- (2016) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple Genetic Pathways Involving Amino Acid Position 143 of HIV-1 Integrase Are Preferentially Associated with Specific Secondary Amino Acid Substitutions and Confer Resistance to Raltegravir and Cross-Resistance to Elvitegravir
- (2013) Wei Huang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started